MIRM
Price:
$99.345
Market Cap:
$4.99B
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Industry
Biotechnology
IPO Date
2019-07-18
Stock Exchange
NASDAQ
Ticker
MIRM
According to Mirum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.30. This represents a change of -134.81% compared to the average of 20.97 of the last 4 quarters.
The mean historical PE Ratio of Mirum Pharmaceuticals, Inc. over the last ten years is -30.32. The current -7.30 PE Ratio has changed 2.31% with respect to the historical average. Over the past ten years (40 quarters), MIRM's PE Ratio was at its highest in in the September 2025 quarter at 366.56. The PE Ratio was at its lowest in in the September 2018 quarter at -493.22.
Average
-30.32
Median
-9.06
Minimum
-169.72
Maximum
-4.27
Discovering the peaks and valleys of Mirum Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 659.54%
Maximum Annual PE Ratio = -4.27
Minimum Annual Increase = -60.20%
Minimum Annual PE Ratio = -169.72
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -169.72 | 659.54% |
| 2024 | -22.35 | 202.55% |
| 2023 | -7.39 | 51.85% |
| 2022 | -4.86 | -15.53% |
| 2021 | -5.76 | 34.88% |
| 2020 | -4.27 | -60.20% |
| 2019 | -10.73 | -38.73% |
The current PE Ratio of Mirum Pharmaceuticals, Inc. (MIRM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-66.48
5-year avg
-42.01
10-year avg
-30.32
Mirum Pharmaceuticals, Inc.’s PE Ratio is greater than Belite Bio, Inc (-61.02), less than Soleno Therapeutics, Inc. (28.75), less than Ligand Pharmaceuticals Incorporated (33.09), less than ADMA Biologics, Inc. (11.72), greater than Praxis Precision Medicines, Inc. (-23.58), less than ACADIA Pharmaceuticals Inc. (9.57), less than Dyne Therapeutics, Inc. (-6.65), greater than Travere Therapeutics, Inc. (-223.18), less than Ultragenyx Pharmaceutical Inc. (-4.02), greater than Telix Pharmaceuticals Limited (-424.33),
| Company | PE Ratio | Market cap |
|---|---|---|
| -61.02 | $5.54B | |
| 28.75 | $2.76B | |
| 33.09 | $5.12B | |
| 11.72 | $1.90B | |
| -23.58 | $5.64B | |
| 9.57 | $3.61B | |
| -6.65 | $3.01B | |
| -223.18 | $4.84B | |
| -4.02 | $2.40B | |
| -424.33 | $3.24B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mirum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mirum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Mirum Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Mirum Pharmaceuticals, Inc. (MIRM)?
What is the highest PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?
What is the 3-year average PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?
What is the 5-year average PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?
How does the current PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM) compare to its historical average?